Tumor necrosis factor-alpha exerts pro-myogenic action in C2C12 myoblasts via sphingosine kinase/S1P2 signaling

FEBS Lett. 2007 Sep 18;581(23):4384-8. doi: 10.1016/j.febslet.2007.08.007. Epub 2007 Aug 14.

Abstract

In this study, we report that low doses of tumor necrosis factor-alpha (TNFalpha) promote myogenesis in C2C12 myoblasts. Moreover, the cytokine increased sphingosine kinase (SphK) activity and induced SphK1 translocation to membranes. The inhibition of SphK functionality by various approaches abrogated the pro-myogenic effect of TNFalpha. Moreover, silencing of S1P(2) impaired the positive action of TNFalpha on myogenesis. These results represent the first evidence that SphK/S1P(2) axis is required for the regulation of myogenesis by TNFalpha. In view of the physiological role of TNFalpha in muscle regeneration, the present finding reinforces the notion that SphK/S1P(2) signaling is critically implicated in myogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Cell Differentiation / drug effects
  • Cell Line
  • Electrophoresis, Polyacrylamide Gel
  • Enzyme Activation / drug effects
  • Myoblasts / cytology
  • Myoblasts / metabolism*
  • Phosphotransferases (Alcohol Group Acceptor) / genetics
  • Phosphotransferases (Alcohol Group Acceptor) / metabolism*
  • RNA, Small Interfering / genetics
  • Signal Transduction / drug effects*
  • Signal Transduction / genetics
  • Signal Transduction / physiology
  • Time Factors
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • RNA, Small Interfering
  • Tumor Necrosis Factor-alpha
  • Phosphotransferases (Alcohol Group Acceptor)
  • sphingosine kinase